Aroflo

Aroflo Mechanism of Action

salmeterol + fluticasone

Manufacturer:

Aristopharma

Distributor:

KTZ
Full Prescribing Info
Action
Pharmacology: Aroflo hydrofluoroalkane (HFA) inhaler is a combination of salmeterol and fluticasone propionate. Salmeterol is a selective, long-acting β2-agonist used in the treatment of asthma and other forms of diffuse airways obstruction. Fluticasone propionate is corticosteroid with potent anti-inflammatory activity. Fluticasone propionate is stated to exert a topical effect on the lungs without systemic effects at usual dose.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in